Chronic kidney disease and heart disease are closely interrelated. Our proprietary Cardio Clinical network exists of 833 sites in 20 different countries, providing access to pioneering expertise and capabilities for CKD research and trials around the world. The network has been involved in various large-scale clinical trials and has extensive experienced staff in performing such trials.
Hemodiafiltration in renal failure reduces the risk of death by 23% compared to hemodialysis
Last Friday, the results of the CONVINCE trial were published in the prestigious New England Journal of Medicine. We are thrilled to announce that the CONVINCE study has shown that the use of high-dose hemodiafiltration led to a remarkable 23% low...